Frontotemporal Lobar Degeneration clinical trials at UCSF

2 in progress, 1 open to eligible people

Frontotemporal lobar degeneration is a brain disease that affects personality and speech. UCSF is researching this disease by monitoring patients over time. These studies help gather valuable data to improve understanding and treatment.

Showing trials for

  • ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

    open to eligible people ages 18 years and up

    ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.

    San Francisco, California and other locations

  • Neurofilament Surveillance Project (NSP)

    Sorry, in progress, not accepting new patients

    This is a biomarker study designed to collect and analyze blood specimens from individuals carrying known familial frontotemporal lobar degeneration (f-FTLD) mutations compared to a control group of individuals without known f-FTLD mutations. The NSP is an ancillary study to the ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration" (ALLFTD) study, NCT04363684. More information can be found at https://www.allftd.org/.

    San Francisco, California and other locations

Our lead scientists for Frontotemporal Lobar Degeneration research studies include .

Last updated: